Pfizer's Inc experimental oral drug that would be the first specifically designed to stop the novel coronavirus could be available by the end of this year. The antiviral pill prevents the virus from spreading inside the body by blocking an enzyme that coronavirus needs to copy itself. The treatment belongs to a class of drugs known as protease inhibitors. Known as PF-07321332, the medication would be prescribed to patients at ...